滅菌サービスの世界市場（2025年～2033年）

世界の滅菌サービスの市場規模は、2024年に38億米ドルに達し、2033年には65億3,000万米ドルに達すると予測され、予測期間2025年～2033年のCAGRは6.4%で成長する見込みです。

滅菌サービスは、医療器具や医療機器が患者に使用される前に生菌がないことを確認するため、医療システムに不可欠なコンポーネントです。この技術は感染予防に不可欠であり、特に病原体が伝染しやすい手術環境では重要です。滅菌サービスには、再使用可能な医療器具の洗浄、消毒、滅菌など、患者の安全性と医療の質に不可欠な作業が幅広く含まれています。

滅菌サービスに対する需要の高まりが、滅菌サービスの世界市場を牽引しています。院内感染に対する懸念の高まりと世界の外科手術件数の増加が、滅菌サービスの需要を高めています。医療施設では、患者の安全性の向上と感染リスクの低減に努めているため、効果的な滅菌技術の必要性が高まっており、これが予測期間の市場を牽引しています。

市場力学：

促進要因と抑制要因

滅菌サービス需要の増加

滅菌サービスに対する需要の増加は、世界の滅菌サービス市場の成長において重要な要因となる見込みです。滅菌サービスの需要が増加している背景には、外科手術の増加や院内感染に対する懸念の高まりがあります。

外科手術の増加に伴い、感染症を抑制するために手術後の手術ユニットや手術器具を滅菌する滅菌サービスの必要性が高まっています。例えば、米国国立衛生研究所（National Institute of Health）によると、2023年には、毎年約40万件のCABG手術が行われ、主要な外科手術の中で最も普及していると報告されています。さらに、2024年の米国国立衛生研究所によると、人工股関節置換術と人工膝関節置換術は米国で最も多く行われている手術の2つであり、推定700万人の米国人が人工股関節または人工膝関節の全置換術を必要とし、毎年100万件以上の置換術が行われています。

毎年数百万人の患者に影響を与え、罹患率と医療支出の増加に寄与している院内感染の蔓延は、厳格な滅菌習慣の必要性を強調しています。このような医療従事者の意識の高まりは、使用前に医療器具や機器から有害な微生物が除去されていることを確認する、信頼性の高い滅菌サービスに対する需要を高めています。このように、手術技術が進歩し、院内感染件数が世界的に増加するにつれて、滅菌サービスの需要が増加し、世界の滅菌サービス市場の急成長を拡大させています。

滅菌サービスに使用される化学薬品の有害な影響

滅菌サービスに使用される化学薬品による有害な影響などが、滅菌サービスの世界市場を妨げると予想されます。熱に敏感な医療機器の滅菌に一般的に使用される酸化エチレン（EtO）とそれに伴う健康リスクは、医療専門家と患者の双方にとって大きな懸念事項です。EtOへの曝露は、呼吸器への刺激、頭痛、さらにはがんや生殖機能障害といったより深刻な疾病を含む、急性および慢性の健康上の懸念を引き起こす可能性があります。EtOがヒトに対する発がん性物質であることが証明されたことで、EtOの使用は複雑化し、その結果、市場拡大の妨げとなりうる監視や規制の圧力が高まっています。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
  • 滅菌サービスの需要増加
  • 抑制要因
  • 滅菌サービスに使用される化学物質の有害な影響
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 償還分析
• 特許分析
• SWOT分析
• DMIの見解

第6章 方法別

• エチレンオキシド滅菌
• ガンマ線滅菌
• 蒸気滅菌
• 電子線滅菌
• その他

第7章 タイプ別

• 契約滅菌サービス
• 滅菌バリデーションサービス

第8章 提供方式別

• オフサイト滅菌サービス
• オンサイト滅菌サービス

第9章 エンドユーザー別

• 病院と診療所
• 医療機器製造会社
• 製薬・バイオテクノロジー企業
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• B. Braun Medical Ltd
  • 会社概要
  • 製品ポートフォリオと概要
  • 財務概要
  • 主な発展
• Stryker Corporation
• BGS Beta-Gamma-Service GmbH & Co. KG
• E-BEAM Services Inc
• Fortive Corporation
• Medistri SA
• MMM Group
• Noxilizer Inc.
• Sotera Health Company
• Steris

第13章 付録

The Global Sterilization Services Market reached US$ 3.8 Billion in 2024 and is expected to reach US$ 6.53 Billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

Sterilization services are essential components of healthcare systems, as they ensure that medical instruments and devices are free of viable bacteria before being used on patients. This technique is critical for infection prevention, especially in surgical settings where pathogens are easily transmitted. Sterilization services include an extensive list of tasks such as cleaning, disinfecting, and sterilizing reusable medical devices, all of which are critical to patient safety and quality of care.

The increasing demand for sterilization services is driving the global sterilization services market. The rising concerns over hospital-acquired infections and the growing number of surgical procedures performed globally are increasing the demand for sterilization services. As healthcare facilities strive to improve patient safety and reduce infection risks, the need for effective sterilization technologies has grown critical, this drives the market over the forecast period.

Market Dynamics: Drivers & Restraints

Increasing demand for sterilization services

The increasing demand for sterilization services is expected to be a significant factor in the growth of the global sterilization services market. The demand for sterilization services is increasing owing to the increasing number of surgical procedures, and rising concerns over hospital-acquired infections.

As the number of surgical procedures increases, there is an increasing need for sterilization services to sterilize the surgical unit and the surgical instruments after the surgery to control the infections. For instance, according to the National Institute of Health, In 2023, it was reported that around 400,000 CABG operations are conducted each year, making it the most prevalent major surgical procedure. Moreover, according to the National Institute of Health in 2024, hip and knee arthroplasty surgeries are two of the most common procedures performed in the United States, with an estimated 7 million Americans necessitating a complete hip or knee replacement and more than 1 million replacements were performed each year.

The prevalence of hospital-acquired infections, which impact millions of patients each year and contribute to increased morbidity and healthcare expenditures, emphasizes the need for strict sterilization practices. This increased awareness among healthcare providers is driving up demand for dependable sterilization services that ensure medical instruments and devices are free of harmful microbes before use. Thus, as surgical techniques advance and the number of hospital-acquired infections rises globally, the demand for sterilization services increases, and the global sterilization services increase market upsurges.

Harmful effects of chemical agents used for sterilization services

Factors such as the harmful effects of chemical agents used for sterilization services are expected to hamper the global sterilization services market. Ethylene Oxide (EtO) which is commonly used for sterilizing heat-sensitive medical devices, and its accompanying health risks are a major concern for both healthcare professionals and patients. EtO exposure can cause a number of acute and chronic health concerns, including respiratory irritation, headaches, and even more serious illnesses like cancer and reproductive health disorders. The recognition of EtO as a proven human carcinogen complicates its use, resulting in increased scrutiny and regulatory pressures that may hinder market expansion.

For more details on this report - Request for Sample

Segment Analysis

The Global sterilization services Market is segmented based on Method, Type, Mode of Delivery, End-User, And Region.

Gamma Sterilization segment is expected to dominate the global sterilization services market share

Gamma sterilization is anticipated to dominate the global sterilization services market owing to its high efficiency and efficacy in delivering consistent and controlled doses during the sterilizing process and technological advancements. This approach is preferred because it can sterilize a wide range of materials without using heat, making it appropriate for heat-sensitive medical devices. The lack of radioactive sourcing or re-sourcing requirements further helps its popularity by simplifying the logistics required in the sterilizing procedure.

The recent technological advancements in gamma sterilization services are one of the major reasons to make it the most dominating segment. There are recent launches of gamma sterilization services that use advanced working principles for quick and efficient sterilization procedures. For instance, in December 2024, a novel Gamma Irradiation Chamber (GIC) 5000, Cobalt-60, was recently launched at Mumbai University's Department of Biophysics, marking a significant step forward in radiation research. The facility is projected to provide considerable opportunity for researchers in various sectors, including healthcare sterilization, food processing, material science, and radiation chemistry.

Technological advancements and an increasing number of surgical procedures that increase the need for quick and efficient sterilization services increase the demand for gamma sterilization, making this segment the most dominating in the global sterilization services market.

Geographical Analysis

North America is expected to hold a significant position in the global sterilization services market share

North America will likely account for a significant share of the global sterilization services market, owing to the increasing number of surgical procedures, rising concerns over hospital-acquired infections, technological advancements, and recent launches.

The increasing number of surgical procedures in this region drives the market. For instance, in the United States, one in every nine people living in residences reported having at least one surgical treatment by 2023. Individuals aged 65 and older, as well as Medicare beneficiaries, had the greatest rates, with around one in every five reporting having undergone surgery. As the increasing number of surgical procedures the number of hospital-acquired infections rises, which increases the demand for sterilization services in North America.

Moreover, the technological advancements drive the market in this region due to the presence of major players and high healthcare investment towards product research and development. For instance, in March 2024, STERIS has recently developed the Verafit Sterilization Bags and Covers, which are intended to help biopharmaceutical producers comply with the updated GMP Annex 1 criteria. Verafit products are produced with Purefit, a flexible sterilizing wrap that reduces contamination concerns from particles, germs, and chemicals. This design is intended to ensure sterility throughout storage and handling. The technological advancements and the increasing number of surgical procedures increase the demand for sterilization services and drive the market in this region.

Asia Pacific is growing at the fastest pace in the global sterilization services market

The Asia Pacific region is emerging as the fastest-growing market for sterilization services, owing to a combination of demographic trends, an increasing number of surgical procedures, rising concerns over hospital-acquired infections, and technological advancements. The increasing number of surgical procedures in this region drives the market. For instance, according to an article published by the Indian Express, each year, an estimated 30 million surgical procedures are performed in India. Significantly, 85% of surgeries are performed in smaller and mid-sized hospitals, with only 15% taking place in corporate hospitals. An increasing number of surgical procedures increases the number of hospital-acquired infections which increases the demand for sterilization services and makes this region the fastest-growing region.

Competitive Landscape

The major global players in the global sterilization services market are B. Braun Medical Ltd, Stryker Corporation, BGS Beta-Gamma-Service GmbH & Co. KG, E-BEAM Services Inc, Fortive Corporation, Medistri SA, MMM Group, Noxilizer Inc., Sotera Health Company, Steris among others.

Emerging Players

Blue Line Sterilization Services, Microtrol Sterilisation Services Pvt Ltd., and Yashodhan Enterprise among others

Key Developments

• In February 2024, Thermo Fisher Scientific has established a new sterile medication facility in Singapore, which will help customers deliver novel medicines and vaccines to the Asia-Pacific market. The new facility features a high-speed, fully automated aseptic fill-finish line for both small and big molecules. This strategic investment in Singapore complements expanded research capabilities at Thermo Fisher Scientific's Customer Experience Center and Bioprocess Design Center, both of which are operational lab facilities that display cutting-edge bioprocessing, life science, and analytical technology.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global sterilization services market report delivers a detailed analysis with 70+ key tables, more than 55 visually impactful figures, and 200 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Method
• 3.2. Snippet by Type
• 3.3. Snippet by Mode of Delivery
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
  • 4.1.2. Rising Demand for Sterilization Services
  • 4.1.3. Restraints
  • 4.1.4. Harmful Effects of Chemical Agents Used for the Sterilization Services
  • 4.1.5. Opportunity
  • 4.1.6. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Reimbursement Analysis
• 5.6. Patent Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Method

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 6.1.2. Market Attractiveness Index, By Method
• 6.2. Ethylene Oxide Sterilization*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Gamma Sterilization
• 6.4. Steam Sterilization
• 6.5. Electron Beam Radiation Sterilization
• 6.6. Others

7. By Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 7.1.2. Market Attractiveness Index, By Type
• 7.2. Contract Sterilization Services*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Sterilization Validation Services

8. By Mode of Delivery

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 8.1.2. Market Attractiveness Index, By Mode of Delivery
• 8.2. Off-Site Sterilization Services*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. On-Site Sterilization Services

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Hospitals and Clinics*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Medical Device Manufacturing Companies
• 9.4. Pharmaceutical and Biotechnology Companies
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Method
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mode of Delivery
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. B. Braun Medical Ltd*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Stryker Corporation
• 12.3. BGS Beta-Gamma-Service GmbH & Co. KG
• 12.4. E-BEAM Services Inc
• 12.5. Fortive Corporation
• 12.6. Medistri SA
• 12.7. MMM Group
• 12.8. Noxilizer Inc.
• 12.9. Sotera Health Company
• 12.10. Steris

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us